Trial Profile
The Expression Level of Molecular Markers that Predict the Effect of Hepatocellular Carcinoma Undergoing Molecular Target Therapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jan 2017
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary) ; Antineoplastics
- Indications Liver cancer
- Focus Therapeutic Use
- 30 Aug 2012 New trial record